首页 > 最新文献

Medical Letter on Drugs and Therapeutics最新文献

英文 中文
Clesrovimab (Enflonsia) for prevention of severe RSV infection in infants. 用于预防婴儿严重呼吸道合胞病毒感染的Clesrovimab (Enflonsia)。
IF 1.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2025-08-18 DOI: 10.58347/tml.2025.1735a
{"title":"Clesrovimab (Enflonsia) for prevention of severe RSV infection in infants.","authors":"","doi":"10.58347/tml.2025.1735a","DOIUrl":"10.58347/tml.2025.1735a","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"67 1735","pages":"129-131"},"PeriodicalIF":1.4,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144823239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In brief: New warning for extended-release stimulants for ADHD. 简而言之:针对多动症的缓释兴奋剂的新警告。
IF 1.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2025-08-18 DOI: 10.58347/tml.2025.1735f
{"title":"In brief: New warning for extended-release stimulants for ADHD.","authors":"","doi":"10.58347/tml.2025.1735f","DOIUrl":"10.58347/tml.2025.1735f","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"67 1735","pages":"135-136"},"PeriodicalIF":1.4,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144823242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mepolizumab (Nucala) for COPD. Mepolizumab (Nucala)用于COPD。
IF 1.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2025-08-18 DOI: 10.58347/tml.2025.1735b
{"title":"Mepolizumab (Nucala) for COPD.","authors":"","doi":"10.58347/tml.2025.1735b","DOIUrl":"10.58347/tml.2025.1735b","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"67 1735","pages":"131-132"},"PeriodicalIF":1.4,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144823246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Linvoseltamab (Lynozyfic) for multiple myeloma. Linvoseltamab (Lynozyfic)治疗多发性骨髓瘤。
IF 1.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2025-08-18 DOI: 10.58347/tml.2025.1735h
{"title":"Linvoseltamab (Lynozyfic) for multiple myeloma.","authors":"","doi":"10.58347/tml.2025.1735h","DOIUrl":"10.58347/tml.2025.1735h","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"67 1735","pages":"e136-e137"},"PeriodicalIF":1.4,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144823245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lenacapavir (Yeztugo) for HIV pre-exposure prophylaxis. Lenacapavir (Yeztugo)用于HIV暴露前预防。
IF 1.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2025-08-18 DOI: 10.58347/tml.2025.1735c
{"title":"Lenacapavir (Yeztugo) for HIV pre-exposure prophylaxis.","authors":"","doi":"10.58347/tml.2025.1735c","DOIUrl":"10.58347/tml.2025.1735c","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"67 1735","pages":"132-134"},"PeriodicalIF":1.4,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144823244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In brief: A new donanemab (Kisunla) dosing regimen for Alzheimer's disease. 简而言之:一种新的多奈马单抗(Kisunla)给药方案治疗阿尔茨海默病。
IF 1.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2025-08-18 DOI: 10.58347/tml.2025.1735d
{"title":"In brief: A new donanemab (Kisunla) dosing regimen for Alzheimer's disease.","authors":"","doi":"10.58347/tml.2025.1735d","DOIUrl":"10.58347/tml.2025.1735d","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"67 1735","pages":"134-135"},"PeriodicalIF":1.4,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144823240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In brief: Hyperthermia with scopolamine patches. 简而言之:东莨菪碱贴片热疗。
IF 1.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2025-08-18 DOI: 10.58347/tml.2025.1735g
{"title":"In brief: Hyperthermia with scopolamine patches.","authors":"","doi":"10.58347/tml.2025.1735g","DOIUrl":"10.58347/tml.2025.1735g","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"67 1735","pages":"136"},"PeriodicalIF":1.4,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144823241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In brief: Pruritus following antihistamine discontinuation. 简而言之:抗组胺停药后出现瘙痒。
IF 1.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2025-08-18 DOI: 10.58347/tml.2025.1735e
{"title":"In brief: Pruritus following antihistamine discontinuation.","authors":"","doi":"10.58347/tml.2025.1735e","DOIUrl":"10.58347/tml.2025.1735e","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"67 1735","pages":"135"},"PeriodicalIF":1.4,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144823243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In brief: A home test for chlamydia, gonorrhea, and trichomoniasis. 简而言之:衣原体、淋病和滴虫病的家庭检测。
IF 1.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2025-05-12 DOI: 10.58347/tml.2025.1728e
{"title":"In brief: A home test for chlamydia, gonorrhea, and trichomoniasis.","authors":"","doi":"10.58347/tml.2025.1728e","DOIUrl":"https://doi.org/10.58347/tml.2025.1728e","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"67 1728","pages":"80"},"PeriodicalIF":1.4,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144022461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concizumab (Alhemo) for hemophilia A and B with inhibitors. conzumab (Alhemo)用于血友病A和B的抑制剂。
IF 1.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2025-05-12 DOI: 10.58347/tml.2025.1728c
{"title":"Concizumab (Alhemo) for hemophilia A and B with inhibitors.","authors":"","doi":"10.58347/tml.2025.1728c","DOIUrl":"https://doi.org/10.58347/tml.2025.1728c","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"67 1728","pages":"76-78"},"PeriodicalIF":1.4,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144058599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medical Letter on Drugs and Therapeutics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1